EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 229 filers reported holding EDITAS MEDICINE INC in Q4 2019. The put-call ratio across all filers is 2.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $8,402,000 | +50.3% | 119,833 | -39.9% | 0.30% | +32.7% |
| Q3 2020 | $5,592,000 | -22.7% | 199,276 | +1.4% | 0.23% | -24.9% |
| Q2 2020 | $7,237,000 | +93.1% | 196,437 | +3.9% | 0.30% | +48.3% |
| Q1 2020 | $3,747,000 | -23.5% | 188,979 | +14.3% | 0.20% | -4.2% |
| Q4 2019 | $4,895,000 | +44.4% | 165,299 | +20.6% | 0.21% | +26.2% |
| Q3 2019 | $3,391,000 | 0.0% | 137,074 | 0.0% | 0.17% | 0.0% |
| Q2 2019 | $3,391,000 | +126.2% | 137,074 | +123.6% | 0.17% | +5.0% |
| Q1 2019 | $1,499,000 | -51.2% | 61,292 | -54.6% | 0.16% | -20.0% |
| Q4 2018 | $3,072,000 | -20.7% | 135,035 | +11.0% | 0.20% | -13.0% |
| Q3 2018 | $3,873,000 | -9.7% | 121,701 | +1.7% | 0.23% | -10.9% |
| Q2 2018 | $4,288,000 | +4.5% | 119,688 | -3.3% | 0.26% | +4.9% |
| Q1 2018 | $4,103,000 | +9.1% | 123,774 | +1.1% | 0.25% | +11.8% |
| Q4 2017 | $3,762,000 | – | 122,424 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |